Category Regulatory

ImmunityBio Secures U.S. Patents for ANKTIVA-BCG Cancer Therapy Through 2035

ImmunityBio Secures U.S. Patent Protection Through 2035 for ANKTIVA-BCG Combination Cancer Therapy ImmunityBio has announced the issuance of five United States patents covering the combination of its IL-15 receptor agonist ANKTIVA with Bacillus Calmette-Guérin for the treatment of cancer, significantly…

Read MoreImmunityBio Secures U.S. Patents for ANKTIVA-BCG Cancer Therapy Through 2035

Agenus Publishes Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Liver Cancer

Agenus Publishes Promising Phase 1b Data for Botensilimab and Balstilimab Combination in Advanced Liver Cancer Agenus has announced the publication of new clinical data highlighting the potential of its investigational immunotherapy combination of botensilimab and balstilimab in patients with advanced…

Read MoreAgenus Publishes Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Liver Cancer

Bayer Launches Midol® in Motion Campaign to Promote PMS Relief Through Physical Activity

Bayer Launches Midol in Motion Campaign to Support PMS Symptom Relief Through Movement and Education Bayer has announced the launch of “Midol in Motion,” a new awareness and education campaign designed to help menstruators better understand and manage common premenstrual…

Read MoreBayer Launches Midol® in Motion Campaign to Promote PMS Relief Through Physical Activity

Affinia Therapeutics Showcases AFTX-201 Cardiomyopathy Data and AAV Platform Advances at ASGCT 2026

Affinia Therapeutics Highlights Advances in Gene Therapy Pipeline and Manufacturing at ASGCT 2026 Affinia Therapeutics showcased major progress across its cardiovascular and central nervous system gene therapy programs during multiple presentations at the 29th Annual Meeting of the American Society…

Read MoreAffinia Therapeutics Showcases AFTX-201 Cardiomyopathy Data and AAV Platform Advances at ASGCT 2026

Heart Failure 2026 Data Highlight Vutrisiran’s Strong Benefits Across ATTR-CM Patient Groups

New Heart Failure 2026 Analyses Highlight Consistent Clinical Benefits of Vutrisiran Across Diverse ATTR-CM Patient Groups Alnylam Pharmaceuticals has announced new analyses from its Phase 3 HELIOS-B clinical trial evaluating vutrisiran in patients with transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM), providing…

Read MoreHeart Failure 2026 Data Highlight Vutrisiran’s Strong Benefits Across ATTR-CM Patient Groups

Dyno Therapeutics Expands Frontiers Network and Unveils Second Annual Genetic Agency Technology Conference

Dyno Therapeutics Expands Frontiers Network and Unveils Second Annual Genetic Agency Technology Conference Dyno Therapeutics, a biotechnology company focused on applying artificial intelligence to advance in vivo gene delivery, has announced major updates to two of its strategic initiatives aimed…

Read MoreDyno Therapeutics Expands Frontiers Network and Unveils Second Annual Genetic Agency Technology Conference

Dr. Carrie Leff Opens Concierge Women’s Primary Care Clinic Focused on Midlife Health in Farmington Hills

Dr. Carrie Leff Opens Concierge Women’s Primary Care Clinic Focused on Midlife Wellness in Farmington Hills Dr. Carrie Leff, a board-certified internist and Menopause Society Certified Practitioner, has officially launched a new concierge-style women’s primary care practice focused on delivering…

Read MoreDr. Carrie Leff Opens Concierge Women’s Primary Care Clinic Focused on Midlife Health in Farmington Hills

Hartford HealthCare Adds MinuteClinic as In-Network Primary Care Option Across Clinically Integrated Network

MinuteClinic and Hartford HealthCare Expand Collaboration to Offer In-Network Adult Primary Care Across Connecticut MinuteClinic, the retail medical clinic network located within select CVS Pharmacy stores, and Hartford HealthCare, one of New England’s largest integrated healthcare systems, have announced an…

Read MoreHartford HealthCare Adds MinuteClinic as In-Network Primary Care Option Across Clinically Integrated Network

Reprieve Cardiovascular Publishes FASTR Pilot Trial Findings in Journal of the American College of Cardiology: Heart Failure

Reprieve Cardiovascular Reports Published FASTR Pilot Study Results Supporting Potential New Approach for Acute Heart Failure Treatment Reprieve Cardiovascular, a development-stage medical technology company focused on transforming the treatment of acute decompensated heart failure (ADHF), has announced the publication of…

Read MoreReprieve Cardiovascular Publishes FASTR Pilot Trial Findings in Journal of the American College of Cardiology: Heart Failure

HiBoop and University of Victoria Join Forces to Transform Mental Health Services at UVic Psychology Clinic

HiBoop and the University of Victoria Join Forces to Advance Mental Health Services at UVic Psychology Clinic Mental health technology company HiBoop has entered into a strategic partnership with the University of Victoria (UVic) to digitize clinical assessment processes at…

Read MoreHiBoop and University of Victoria Join Forces to Transform Mental Health Services at UVic Psychology Clinic

HemoSonics’ Quantra Hemostasis System Earns Silver Honor at the 2026 Edison Awards for Advancing Obstetric Care

HemoSonics’ Quantra Hemostasis System Earns Silver at the 2026 Edison Awards for Advancing Obstetric Care HemoSonics LLC, a medical device innovator specializing in acute bleeding management, has earned significant industry recognition for its advancements in maternal healthcare. The company announced…

Read MoreHemoSonics’ Quantra Hemostasis System Earns Silver Honor at the 2026 Edison Awards for Advancing Obstetric Care